Administration, Evaluation, and Planning Core

管理、评估和规划核心

• 批准号: 7314583
• 负责人: PHILIP W KANTOFF
• 金额: $ 50.24万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7314583
• 关键词: Academy; Administrator; Applications Grants; Area; Basic Science; Boston; Businesses; Cancer Center; Cancer Survivor; Center Core Grants; Charge; Collaborations; Communication; Communities; Decision Making; Development; Discipline; Doctor of Philosophy; Doctor of Public Health; Educational Activities; Educational workshop; Ensure; Epidemiology; Evaluation; Event; Fostering; Funding; Future; Grant; Guidelines; Individual; Institution; Intellectual Property; Intranet; Israel; Leadership; Licensing; Malignant neoplasm of prostate; Medical center; Monitor; Names; Nodal; Operative Surgical Procedures; Population Sciences; Principal Investigator; Program Development; Progress Reports; Prostate; Public Health Schools; Publications; Purpose; Report (account); Reporting; Reproduction spores; Research; Research Personnel; Resources; Rights; Secure; Signal Transduction; Specialist; Structure; Systems Biology; Technology; Technology Transfer; Travel; Universities; Work; anticancer research; authority; career; complement resource; cost; day; experience; interest; medical schools; member; nutrition; professor; programs; success; tool

The purpose of the Administration, Evaluation, and Planning Core is to ensure the coordination of the Dana- Farber/Harvard Cancer Center (DF/HCC) Prostate Cancer SPORE components and to provide oversight and leadership of the scientific, administrative, and fiscal aspects of the SPORE. Within the DF/HCC Prostate Cancer SPORE, there are several layers of oversight and evaluation. Dr. Kantoff, as SPORE Director, monitors the progress of the Projects and Cores and oversees the Career Development Program (along with Drs.Sanda and D'Amico), the Developmental Projects Program (along with Drs.Cantley and Stampfer), and all other proposed activities. Within the DF/HCC, Dr. Kantoff has the authority and resources to ensure the success of this SPORE. Our Governance Committee, made up of senior members of the DF/HCC Prostate Cancer Program, meet monthly to provide immediate decision- making. We have two strong Co-Pis. Dr. Kantoff will be joined by Lewis Cantley, PhD, Professor of Systems Biology and Chief, Division of Signal Transduction at the Beth Israel Deaconess Medical Center, to assume the responsibility as Co-Pi of the SPORE. Dr. Cantley, a member of the National Academy since 2001 and the PI of a PO1 on signal transduction in prostate cancer, brings outstanding basic science expertise to our Program and SPORE. Meir Stampfer, MD, Dr.P.H., Professor of Nutrition and Epidemiology, Chair, Department of Epidemiology, Harvard School of Public Health, will also serve as Co-Pi. Given Dr. Stampfer's interest and expertise in prostate cancer and the centrality of population science in this SPORE application, his leadership is welcome. We have a strong Internal Advisory Board, comprised of prominent members of the Harvard Medical School community and representing the participating institutions and major cancer research disciplines. Our External Advisory Board will meet in the Boston area annually during the five-year funding cycle. The membership and functions of these committees are discussed in detail in the description of this Core. The Administration, Evaluation, and Planning Core allows for the provision of stimulating intellectual activities, organization of venues for planning future research through seminars and retreats, and the oversight of research and spending. This Core also provides the tools to work with institutions inside and outside of Harvard University to leverage the considerable power of the SPORE in order to raise more research funding for prostate cancer.

政府，评估和规划核心的目的是确保达纳的协调 Farber/Harvard癌症中心（DF/HCC）前列腺癌孢子成分并提供监督 以及孢子科学，行政和财政方面的领导。 在DF/HCC前列腺癌孢子中，有几层监督和评估。博士 坎托夫（Kantoff）作为孢子主管，监视项目和核心的进步，并监督职业 开发计划（以及Sanda和D'Amico博士），开发项目计划（同时 与坎特利（Cantley）和Stampfer博士一起）以及所有其他建议的活动。在DF/HCC中，Kantoff博士拥有 确保孢子成功的权威和资源。我们的治理委员会由 DF/HCC前列腺癌计划的高级成员，每月开会以立即做出决定 - 制作。我们有两个强大的共同理学。 Kantoff博士将由系统教授Lewis Cantley博士加入 贝丝以色列执事医疗中心的生物学和首席，贝斯的信号转导司 作为孢子的副派的责任。自2001年以来，Cantley博士是美国国家学院的成员 PO1关于前列腺癌信号转导的PI，为我们带来了杰出的基础科学专业知识 程序和孢子。 Meir Stampfer，医学博士，P.H.博士，营养与流行病学教授，主席， 哈佛大学公共卫生学院流行病学系也将担任Co-Pi。鉴于Stampfer博士 在这种孢子应用中，对前列腺癌的兴趣和专业知识以及人口科学的中心地位， 欢迎他的领导。我们有一个强大的内部顾问委员会，由 哈佛医学院社区，代表参与机构和大型癌症 研究学科。我们的外部顾问委员会将在五年内每年在波士顿地区开会 资金周期。这些委员会的成员和职能在描述中详细讨论 这个核心。 政府，评估和计划核心允许提供刺激的智力 活动，通过研讨会和务虚会计划未来研究的场所的组织以及 监督研究和支出。该核心还提供了与内部机构合作的工具 在哈佛大学以外 研究资金用于前列腺癌。